人乳头瘤病毒(HPV)相关与非相关口咽癌根治性放疗后失败几何模式差异
本研究在单一三级机构中评估根治性调强放疗后复发口咽鳞状细胞癌患者的局部区域失败空间模式,按剂量分布和靶区分五型比较p16阳性与阴性肿瘤。58处复发中66%位于淋巴结,p16阴性较p16阳性更易发生周边型复发(32% vs. 7%),p16阳性更易发生野外型复发(17% vs. 0%),失败类型差异有统计学意义(X2 9.52,p=0.044)。
要点
- 58处局部区域复发中66%(38/58)位于淋巴结区域。
- p16阴性肿瘤周边型复发32% vs. p16阳性7%。
- p16阳性肿瘤野外型复发17% vs. p16阴性0%。
核心结论
- 在基于共识靶区勾画和现代放疗的口咽癌患者中,局部区域失败模式在p16阳性和p16阴性肿瘤间存在显著差异。
- 作者认为需要进一步的确证性失败模式研究,以便未来为口咽恶性肿瘤患者实现更个体化的放疗。
研究设计与样本
- 在单一三级机构识别根治性调强放疗后发生局部区域复发的患者。
- 靶区按最新国际共识指南勾画,复发按既往验证方法基于放疗剂量分布和靶区分五型:A型(中心高剂量)、B型(周边高剂量)、C型(中心择期剂量)、D型(周边择期剂量)、E型(野外剂量)。
- 使用Pearson卡方检验比较p16阳性与p16阴性肿瘤的失败类型。
主要发现
- 36例患者中观察到58处局部区域复发,多数位于淋巴结(66%,38/58)。
- 58处复发中34处(59%)为A型,6处(10%)为B型,9处(15%)为C型,5处(9%)为D型,4处(7%)为E型。
- p16阳性与p16阴性肿瘤的失败类型差异有统计学意义(X2 9.52,p=0.044)。
- p16阴性肿瘤较p16阳性更易发生周边型复发(32% vs. 7%)。
- p16阳性肿瘤较p16阴性更易发生野外型复发(17% vs. 0%)。
关键数值与推荐
- 复发分型:A型中心高剂量、B型周边高剂量、C型中心择期剂量、D型周边择期剂量、E型野外剂量。
- p16阴性肿瘤周边型复发32% vs. p16阳性7%。
- p16阳性肿瘤野外型复发17% vs. p16阴性0%。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文指出需要进一步的确证性失败模式研究,以便未来为口咽恶性肿瘤患者实现更个体化的放疗。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: The aim of this study was to evaluate and compare the spatial pattern of locoregional recurrences in patients diagnosed with HPV-associated and HPV-non-associated oropharyngeal SCC (OPSCC) treated with definitive radiotherapy. METHODS AND MATERIALS: Patients who had locoregional recurrence following definitive intensity-modulated radiation therapy were identified at a single tertiary institution. Target volumes were delineated according to the latest consensus international guidelines. Recurrences were classified into five categories based on radiotherapy dose distribution and target volume, using a previously validated methodology; type A (central high dose), type B (peripheral high dose), type C (central elective dose), type D (peripheral elective dose), and type E (extraneous dose). The types of failure were compared between p16-positive and p16-negative tumors using the Pearson chi-square test. RESULTS: Fifty-eight locoregional recurrences were observed in 36 patients. The majority of recurrences were in nodal locations (66%, 38/58). Among these, 34 (59%) were classified as type A, 6 (10%) as type B, 9 (15%) as type C, 5 (9%) as type D, and 4 (7%) as type E failure. A significant difference was found in the types of failure between p16-positive and p16-negative tumors (X2 9.52, p = 0.044). p16-negative tumors were more likely to have recurrences in a peripheral location compared to p16-positive tumors (32% vs. 7%). p16-positive tumor were more likely to have extraneous recurrences (17% vs. 0%). CONCLUSION: Our study results identified a significant difference in patterns of locoregional failure among patients diagnosed with oropharyngeal cancer following consensus-based tumor delineation and modern radiotherapy. Further confirmatory pattern of failure studies are required to enable greater individualization of radiotherapy for patients diagnosed with oropharyngeal malignancy in the future.
引用
- Yuvnik T, Chia L, Laura OC, et al. Differences in geometric patterns of failure in human papillomavirus (HPV)-associated and HPV-non-associated oropharyngeal cancer after definitive radiotherapy. Head Neck. 2023. PMID: 38108534. doi:10.1002/hed.27606
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。